Journal profile · Respiratory System

Revue des Maladies Respiratoires

ISSN 0761-8425 · eISSN 1776-2588 · Elsevier Masson · FRANCE · Bimonthly · Founded 1984

Revue des Maladies Respiratoires: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.38; subscription journal; APC about USD 3,000; median 178 days to acceptance (75 articles, last 24 months); community-reported acceptance: easy; 159 articles in 2025; indexed in SCIE and Scopus.

Impact factor0.38Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time178 daysMedian, submission to acceptance · 75 articles, last 24 months · PubMed
APCUSD 3,000Subscription journal
AcceptanceEasyCommunity average
Articles per year1592025 · OpenAlex count

Scope

Aims, scope and focus

Revue des Maladies Respiratoires is published by Elsevier Masson and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Asthma and respiratory diseases, together about 23.4% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Organe officiel d’expression scientifique de la Société de Pneumologie de Langue Française (SPLF), la Revue des Maladies Respiratoires est une publication scientifique destinée à tous les acteurs impliqués directement ou indirectement dans la prise en charge des patients atteints de pathologie respiratoire. La Revue publie en langue française et au format électronique les travaux de recherche de qualité issus des équipes francophones ainsi que des documents de formation concernant les maladies respiratoires, dans le cadre des rubriques suivantes : Éditoriaux, Articles originaux, Revues générales (souvent dans le cadre de Séries thématiques), Synthèses ou Mises au point, Recommandations d’experts et textes de consensus, Fiches techniques, Cas cliniques ou articles « images et diagnostics », Lettres à la rédaction.Pour accéder au site de la Revue des Maladies Respiratoires cliquez ici

From the journal's Aims & Scope

Research area (LetPub): Respiratory System

Editorial board by country: none in mainland China; most named France 15, Belgium 2 (17 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine10.9%
  2. Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine6.3%
  3. Asthma and respiratory diseasesMedicine6.2%
  4. Pleural and Pulmonary DiseasesMedicine5.9%
  5. Tuberculosis Research and EpidemiologyMedicine5.9%
  6. Lung Cancer Diagnosis and TreatmentMedicine5.5%
  7. Respiratory Support and MechanismsMedicine5.1%
  8. Lung Cancer Treatments and MutationsMedicine4.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRespiratory SystemZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRespiratory SystemZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRespiratory SystemZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
0.38LetPub ·
Impact factor (publisher)
0.5Publisher website ·
CiteScore 2026-06
1.1LetPub ·
CiteScore (publisher)
1.1Publisher website ·
SJR 2026-06
0.19LetPub ·
SNIP 2026-06
0.29LetPub ·
h-index
27LetPub ·
h-index
40OpenAlex ·
i10-index
632OpenAlex ·
2-year mean citedness
0.25OpenAlex ·
Self-citation rate
20%LetPub ·
Share of gold OA articles
4.52%LetPub ·

Volume

Articles per year
50LetPub ·

Articles by year OpenAlex count · 13,484 in total · the current year is incomplete

YearArticlesOpen accessCitations
20269191
20251591826
20241976483
202320480175
202217465249
202120375388

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

178 daysMedian, submission to acceptance · P25–P75 107 days – 240 days

Acceptance to online
median 39 days (75 articles)
Submission to online
median 214 days
Sample
75 articles with submission and acceptance dates (111 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
4–8 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 3,000——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Elsevier Masson
Country or region
FRANCE
Language
French
Frequency
Bimonthly
Founded
1984
ISSN
0761-8425
Electronic ISSN
1776-2588
Official links

FAQ

Frequently asked questions about Revue des Maladies Respiratoires

What CAS zone is Revue des Maladies Respiratoires in?

In the 2025 upgraded edition of the CAS Journal Ranking, Revue des Maladies Respiratoires is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Revue des Maladies Respiratoires?

The latest impact factor listed by LetPub is 0.38; CiteScore 1.1, h-index 40.

How long does peer review take at Revue des Maladies Respiratoires?

Based on the dates recorded on 75 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 178 days (interquartile range 107–240 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Revue des Maladies Respiratoires based?

Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (15) and Belgium (2). Counted from the institutions listed on the board page; for reference only.

Which databases index Revue des Maladies Respiratoires?

According to LetPub and DOAJ records, Revue des Maladies Respiratoires is indexed in SCIE and Scopus.

Is Revue des Maladies Respiratoires open access, and what is the APC?

Revue des Maladies Respiratoires is a subscription journal. APC about USD 3,000.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .